Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

OCUL holding history

Ocular Therapeutix, Inc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings

Shares (Q2 2026)
378,754
Value
$3.72M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of OCUL by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026378,754$3.72M<0.1%−769,228−67.0%ReducedHolders
Q1 20261,147,982$9.72M<0.1%+356,782+45.1%AddedHolders
Q4 2025791,200$9.61M<0.1%+791,200NewHolders
Q3 20250$00.0%−410,048−100.0%Sold outHolders
Q2 2025410,048$3.81M<0.1%−43,952−9.7%ReducedHolders
Q1 2025454,000$3.33M<0.1%+454,000NewHolders
Q2 20240$00.0%−29,700−100.0%Sold outHolders
Q1 202429,700$270.0K<0.1%+29,700NewHolders
Q4 20230$00.0%−125,200−100.0%Sold outHolders
Q3 2023125,200$393.0K<0.1%+100,307+403.0%AddedHolders
Q2 202324,893$128.0K<0.1%−46,300−65.0%ReducedHolders
Q1 202371,193$375.0K<0.1%−222,800−75.8%ReducedHolders
Q4 2022293,993$826.0K<0.1%+279,200+1,887.4%AddedHolders
Q3 202214,793$61.0K<0.1%−366,707−96.1%ReducedHolders
Q2 2022381,500$1.53M<0.1%−129,305−25.3%ReducedHolders
Q1 2022510,805$2.53M<0.1%+430,705+537.7%AddedHolders
Q4 202180,100$558.0K<0.1%−166,100−67.5%ReducedHolders
Q3 2021246,200$2.46M<0.1%−80,922−24.7%ReducedHolders
Q2 2021327,122$4.64M<0.1%+277,222+555.6%AddedHolders
Q1 202149,900$819.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.